@liensofnewyork Still think MSD next year is reasonable? Low income skew, lapping stimulus, delivery heavy in a reopen environment, and no value platform. 4Q data says traffic degrading w/ 4-5% pricing
@LSValue Great unit economics, highly visible 25% EBITDA growth for next 5 yrs, arguably created a category, cult fan base, largely immune from labor + commodity inflation, solid mgmt team. Not cheap, but this co is the real deal. May I suggest $SG as an alternative stock going to $15?
@Ricksalin High income consumer in great shape, impressive digital gains (esp. in China), high-margin cold-beverage led growth, pricing power, insane unit economics, ESG fund flows...and they sell a drug
That said: 3x PEG, COO/CFO left w/in 1 mo. of each other, China / labor inflation risk